PD-1/PD-L1-IN-10
PD-1/PD-L1-IN-10 (compound B2) is an orally active PD-1/PD-L1 inhibitor (IC50 of 2.7 nM) with potent anticancer efficacy[1].
Product Specifications
CAS Number
[2487550-41-2]
UNSPSC
12352005
Target
Apoptosis; PD-1/PD-L1
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-pd-l1-in-10.html
Purity
99.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(C=CC=C1C2=CC=CC=C2)COC3=C(C=C(C(OCC4=CC(C#N)=CC=C4)=C3)CN[C@H](C(O)=O)C(O)C)[N+]([O-])=O
Molecular Formula
C33H31N3O7
Molecular Weight
581.62
References & Citations
[1]Yiqiang OuYang, et al. Design, Synthesis, and Evaluation of o- (Biphenyl-3-ylmethoxy) nitrophenyl Derivatives as PD-1/PD-L1 Inhibitors with Potent Anticancer Efficacy In Vivo. J Med Chem. 2021 May 26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
1216418 25 PCS/PCK
Versitec Tube, 15.00 x 3.00 mm (Sales Unit: 25 m)
Sign In for Pricing
View Details 
GTR15156098 1 Vial
Lentiviral human MRNIP shRNA (UAS) - Lentiviral human MRNIP shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
S1013-57E13-ML550 100 µL
Siglec 1 (Sialic Acid Binding Ig-like Lectin 1, CD169, CD169 Antigen, dJ1009E24.1, DKFZp667F058, FLJ00051, FLJ00055, FLJ00073, FLJ00411, FLJ32150, Sialic Acid-binding Ig-like Lectin 1, Sialic Acid-binding Ig-like Lectin-1, Sialoadhesin, Sialoadhesin Precursor, Siglec 1, SN) (MaxLight 550)
Sign In for Pricing
View Details